Search results
AbCellera Biologics Inc (ABCL) Reports Q3 2023 Earnings: Revenue Drops to $7 Million
GuruFocus.com via Yahoo Finance· 6 months agoAbCellera Biologics Inc (NASDAQ:ABCL) reported a total revenue of $7 million in Q3 2023, a...
Does AbCellera Biologics Inc. (ABCL) Have the Potential to Rally 242.09% as Wall Street Analysts...
Zacks via Yahoo Finance· 9 months agoThe average of price targets set by Wall Street analysts indicates a potential upside of 242.1% in...
IBD Stock Of The Day AbCellera Is Pulling Back — Why Investors Should Be Paying Attention
Investor's Business Daily· 1 year agoAntibody machine AbCellera Biologics is the IBD Stock Of The Day as ABCL stock eyes a potential...
AbCellera Biologics Inc.'s (NASDAQ:ABCL) Fundamentals Look Pretty Strong: Could The Market Be Wrong...
Simply Wall St. via Yahoo Finance· 1 year agoIt is hard to get excited after looking at AbCellera Biologics' (NASDAQ:ABCL) recent performance,...
AbCellera (ABCL) to Develop New Antibody Therapies With AbbVie
Zacks via Yahoo Finance· 1 year agoAbCellera Biologics Inc. ABCL announced that it entered a multi-target strategic collaboration with...
AbCellera Biologics Inc. (ABCL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks via Yahoo Finance· 2 years agoAbCellera Biologics Inc. (ABCL) possesses the right combination of the two key ingredients for a...
AbCellera Biologics Inc. (NASDAQ:ABCL) institutional owners may be pleased with recent gains after...
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in AbCellera Biologics Inc. (NASDAQ:ABCL) should be aware of the most powerful...
3 Biotech Stocks Under $10 to Add to Your Buy List
InvestorPlace via Yahoo Finance· 2 years agoAbCellera Biologics (ABCL): Impressive sales growth is very promising for this firm and its antibody discovery platform. SIGA Technologies (SIGA):...
Strong week for AbCellera Biologics (NASDAQ:ABCL) shareholders doesn't alleviate pain of one-year...
Simply Wall St. via Yahoo Finance· 11 months agoIt's nice to see the AbCellera Biologics Inc. (NASDAQ:ABCL) share price up 16% in a week. But that...
Institutional investors may adopt severe steps after AbCellera Biologics Inc.'s (NASDAQ:ABCL) latest...
Simply Wall St. via Yahoo Finance· 8 months agoKey Insights Given the large stake in the stock by institutions, AbCellera Biologics' stock price...